TY - JOUR
T1 - Consumer credit as a novel marker for economic burden and health after cancer in a diverse population of breast cancer survivors in the USA
AU - Dean, Lorraine T.
AU - Schmitz, Kathryn H.
AU - Frick, Kevin D.
AU - Nicholas, Lauren H.
AU - Zhang, Yuehan
AU - Subramanian, S. V.
AU - Visvanathan, Kala
N1 - Publisher Copyright:
© 2017, The Author(s).
PY - 2018/6/1
Y1 - 2018/6/1
N2 - Background: Consumer credit may reflect financial hardship that patients face due to cancer treatment, which in turn may impact ability to manage health after cancer; however, credit’s relationship to economic burden and health after cancer has not been evaluated. Methods: From May to September 2015, 123 women with a history of breast cancer residing in Pennsylvania or New Jersey completed a cross-sectional survey of demographics, socioeconomic position, comorbidities, SF-12 self-rated health, economic burden since cancer diagnosis, psychosocial stress, and self-reported (poor to excellent) credit quality. Ordinal logistic regression evaluated credit’s contribution to economic burden and self-rated health. Results: Mean respondent age was 64 years. Mean year from diagnosis was 11.5. Forty percent of respondents were Black or Other and 60% were White. Twenty-four percent self-reported poor credit, and 76% reported good to excellent credit quality. In adjusted models, changing income, using savings, borrowing money, and being unable to purchase a health need since cancer were associated with poorer credit. Better credit was associated with 7.72 ([1.22, 14.20], p = 0.02) higher physical health t-score, and a − 2.00 ([− 3.92, − 0.09], p = 0.04) point change in psychosocial stress. Conclusions: This exploratory analysis establishes the premise for consumer credit as a marker of economic burden and health for breast cancer survivors. Future work should validate these findings in larger samples and for other health conditions. Implications for Cancer Survivors: Stabilizing and monitoring consumer credit may be a potential intervention point for mitigating economic burden after breast cancer.
AB - Background: Consumer credit may reflect financial hardship that patients face due to cancer treatment, which in turn may impact ability to manage health after cancer; however, credit’s relationship to economic burden and health after cancer has not been evaluated. Methods: From May to September 2015, 123 women with a history of breast cancer residing in Pennsylvania or New Jersey completed a cross-sectional survey of demographics, socioeconomic position, comorbidities, SF-12 self-rated health, economic burden since cancer diagnosis, psychosocial stress, and self-reported (poor to excellent) credit quality. Ordinal logistic regression evaluated credit’s contribution to economic burden and self-rated health. Results: Mean respondent age was 64 years. Mean year from diagnosis was 11.5. Forty percent of respondents were Black or Other and 60% were White. Twenty-four percent self-reported poor credit, and 76% reported good to excellent credit quality. In adjusted models, changing income, using savings, borrowing money, and being unable to purchase a health need since cancer were associated with poorer credit. Better credit was associated with 7.72 ([1.22, 14.20], p = 0.02) higher physical health t-score, and a − 2.00 ([− 3.92, − 0.09], p = 0.04) point change in psychosocial stress. Conclusions: This exploratory analysis establishes the premise for consumer credit as a marker of economic burden and health for breast cancer survivors. Future work should validate these findings in larger samples and for other health conditions. Implications for Cancer Survivors: Stabilizing and monitoring consumer credit may be a potential intervention point for mitigating economic burden after breast cancer.
UR - http://www.scopus.com/inward/record.url?scp=85040912203&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85040912203&partnerID=8YFLogxK
U2 - 10.1007/s11764-017-0669-1
DO - 10.1007/s11764-017-0669-1
M3 - Article
C2 - 29372485
AN - SCOPUS:85040912203
SN - 1932-2259
VL - 12
SP - 306
EP - 315
JO - Journal of Cancer Survivorship
JF - Journal of Cancer Survivorship
IS - 3
ER -